RNA Therapeutics: Opening New Pathways for Rare Disease Treatment
Frost & Sullivan Podcasts
RNA therapeutics are creating new possibilities for treating rare diseases closer to their underlying genetic cause.
In this episode of Frost & Sullivan’s Growth Podcast, we explore how antisense oligonucleotides (ASOs), small interfering RNA (siRNA), and messenger RNA (mRNA) are advancing disease-modifying treatment across genetically defined rare diseases. We examine the emergence of personalized N-of-1 therapies, the persistent challenge of tissue-specific delivery, and how Artificial Intelligence could accelerate RNA drug discovery and development.
👉 How are different RNA modalities addressing genetically driven rare diseases?
👉 Could personalized RNA therapeutics create viable treatment pathways for ultra-rare patient populations?
👉 How will AI and next-generation delivery technologies shape the next wave of RNA innovation?
Designed for biopharmaceutical companies, biotechnology innovators, investors, healthcare stakeholders, and R&D leaders, this episode examines the technologies and growth opportunities shaping the future of RNA therapeutics in rare disease treatment.
Explore related research:
https://www.frost.com | https://store.frost.com
Connect with our team: hello@frost.com
Loading